NewAmsterdam Pharma (NAMSW) Institutional Ownership $13.59 +0.22 (+1.65%) (As of 11/14/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMSW)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.26MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$13.99K Get NAMSW Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMSW Institutional Buying and Selling by Quarter Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/23/2024 TFC Financial Management Inc.10,000$87K0.0%N/A0.000% 5/15/2024 Affinity Asset Advisors LLC202,599$2.24M0.3%+47.9%0.000% 2/15/2024Clear Street LLC8,993$28K0.0%-33.2%0.000% 2/14/2024ADAR1 Capital Management LLC82,857$259K0.1%N/A0.000% 11/15/2023 Affinity Asset Advisors LLC137,000$260K0.1%+270.3%0.000% 8/7/2023 Wolverine Asset Management LLC12,448$26K0.0%N/A0.000% 5/15/2023 Affinity Asset Advisors LLC37,000$68K0.0%N/A0.000% 5/12/2023Clear Street LLC17,619$32K0.0%N/A0.000% 5/11/2023 Highbridge Capital Management LLC733,327$1.36M0.0%+4.0%0.000% 5/10/2023Exos TFP Holdings LLC93,932$173K0.0%-31.6%0.000% 2/14/2023RA Capital Management L.P.333,333$289K0.0%N/A0.000% 2/14/2023EcoR1 Capital LLC66,665$727K0.0%N/A0.000% 2/10/2023Exos TFP Holdings LLC137,317$119K0.0%N/A0.000% 2/3/2023Frazier Life Sciences Management L.P.500,333$434K0.0%N/A0.000% (Data available from 1/1/2016 forward) NAMSW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMSW shares? During the previous two years, 10 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Affinity Asset Advisors LLC ($2.24M), Highbridge Capital Management LLC ($1.36M), EcoR1 Capital LLC ($727K), Frazier Life Sciences Management L.P. ($434K), RA Capital Management L.P. ($289K), ADAR1 Capital Management LLC ($259K), and Exos TFP Holdings LLC ($173K).Learn more on NAMSW's institutional investors. Which institutional investors have been buying NewAmsterdam Pharma stock? Of the 10 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($500.33K), RA Capital Management L.P. ($333.33K), Affinity Asset Advisors LLC ($202.60K), Exos TFP Holdings LLC ($137.32K), ADAR1 Capital Management LLC ($82.86K), EcoR1 Capital LLC ($66.67K), and Highbridge Capital Management LLC ($27.98K). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 1,391,146 shares in the last 24 months. This purchase volume represents approximately $2.34M in transactions. Which NewAmsterdam Pharma major shareholders have been selling company stock? The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Exos TFP Holdings LLC ($43.39K), and Clear Street LLC ($4.47K). How much institutional selling is happening at NewAmsterdam Pharma? Institutional investors have sold a total of 47,855 shares in the last 24 months. This volume of shares sold represents approximately $93.82K in transactions. This page (NASDAQ:NAMSW) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
